SynthesisThe Journal of infection2022

Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis.

Ling Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.